A detailed history of Regal Investment Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Regal Investment Advisors LLC holds 2,170 shares of NVO stock, worth $189,592. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,170
Previous 1,961 10.66%
Holding current value
$189,592
Previous $279,000 7.53%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $24,885 - $30,392
209 Added 10.66%
2,170 $258,000
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $2,822 - $3,378
-23 Reduced 1.16%
1,961 $279,000
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $202,586 - $269,665
1,984 New
1,984 $254,000
Q2 2019

Jul 26, 2019

SELL
$46.79 - $52.47 $182,621 - $204,790
-3,903 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$46.36 - $52.63 $180,943 - $205,414
3,903 New
3,903 $204,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Regal Investment Advisors LLC Portfolio

Follow Regal Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regal Investment Advisors LLC with notifications on news.